De novo malignancies following liver transplantation: Impact and recommendations

Liver Transplantation

Volumn 15, Issue SUPPL. 2, 2009, Pages

  Herrero, J Ignacio ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AGING; ARTICLE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HEAD AND NECK CANCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CANCER; SMOKING; SUN EXPOSURE; SURGICAL MORTALITY; CHEMICALLY INDUCED DISORDER; INCIDENCE; MORTALITY; NEOPLASM; RISK FACTOR; SURVIVAL;

HUMANS; IMMUNOSUPPRESSION; INCIDENCE; LIVER TRANSPLANTATION; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77449140353     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21898     Document Type: Article

References (23)

1. Vanlemmens C, Di Martino V, Milan C, Messner M, Minello A, Duvoux C, et al. Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis. A randomized trial. Ann Intern Med 2009; 150: 153-161.
2. Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11: 89-97. (Pubitemid 40124447)
3. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 84-91. (Pubitemid 32102556)
4. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69: 781-789. (Pubitemid 30174097)
5. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM,. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005; 80: 759-764.
6. Åberg F, Pukkala E, Höckerstedt K, Sankila R, Isoniemi H,. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008; 14: 1428-1436.
7. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM,. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67.
8. Herrero JI, España A, Quiroga J, Sangro B, Pardo F, Alvárez-Cienfuegos J, Prieto J,. Non-melanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl 2005; 11: 1100-1106. (Pubitemid 41341760)
9. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B,. De novo malignancies after liver transplantation: a major cause of death. Liver Transpl 2001; 7: S109-S118. (Pubitemid 33100360)
10. Herrero JI, Alegre F, Quiroga J, Pardo F, Iñarrairaegui M, Sangro B, et al. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009; 23: 532-538.
11. Hoffmann CJ, Subramanian AK, Cameron AN, Engels EA,. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation 2008; 86: 784-790.
12. Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7: 811-815. (Pubitemid 32851304)
13. Bakker NA, Van Imhoff GW, Verschuuren EAM, van Son WJ,. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Transpl Int 2007; 20: 207-218. (Pubitemid 46246535)
14. Euvrard S, Kanitakis J,. Skin cancers after liver transplantation: what to do? J Hepatol 2006; 44: 27-32. (Pubitemid 41772512)
15. Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, Rayõn M, et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4: 596-604. (Pubitemid 38523582)
16. Monaco AP,. The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation 2009; 87: 157-163.
17. Herrero JI, Lucena JF, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 2003; 3: 1407-1412. (Pubitemid 37288086)
18. Presser SJ, Schumacher G, Neuhaus R, Thuss-Patience P, Stieler J, Neuhaus P,. De novo esophageal neoplasia after liver transplantation. Liver Transpl 2007; 13: 443-450. (Pubitemid 46444474)
19. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T,. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med 2009; 150: 199-205.
20. Hierro L, Díez-Dorado R, Díaz C, De la Vega A, Frauca E, Camarena C, et al. Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein-Barr virus. Liver Transpl 2008; 14: 1185-1193.
21. Green M, Mazariegos GV,. Persistent detection of Epstein-Barr virus DNA after pediatric liver transplantation: unclear risks and uncertain responses. Liver Transpl 2008; 14: 1077-1080.
22. Leithead JA, Ferguson JW, Hayes PC,. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl 2008; 14: 1159-1164.
23. Benedetti A, Parent M-E, Siemiatycki J,. Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal. Cancer Detect Prev 2009; 32: 352-362.